Yushan Cheng - Search Results

Year	Number of Results
2007	1
2009	1
2010	2
2012	1
2013	2
2014	3
2015	1
2016	4
2018	6
2019	9
2020	6
2021	10
2022	5
2023	5
2024	1

1

Drug combination therapy for emerging viral diseases.

Shyr ZA, Cheng YS, Lo DC, Zheng W. Shyr ZA, et al. Drug Discov Today. 2021 Oct;26(10):2367-2376. doi: 10.1016/j.drudis.2021.05.008. Epub 2021 May 21. Drug Discov Today. 2021. PMID: 34023496 Free PMC article. Review.

2

Improving therapy of severe infections through drug repurposing of synergistic combinations.

Cheng YS, Williamson PR, Zheng W. Cheng YS, et al. Curr Opin Pharmacol. 2019 Oct;48:92-98. doi: 10.1016/j.coph.2019.07.006. Epub 2019 Aug 24. Curr Opin Pharmacol. 2019. PMID: 31454708 Free PMC article. Review.

3

Facilitated Unbinding via Multivalency-Enabled Ternary Complexes: New Paradigm for Protein-DNA Interactions.

Chen TY, Cheng YS, Huang PS, Chen P. Chen TY, et al. Acc Chem Res. 2018 Apr 17;51(4):860-868. doi: 10.1021/acs.accounts.7b00541. Epub 2018 Jan 25. Acc Chem Res. 2018. PMID: 29368512 Free PMC article. Review.

4

Zika Virus-Induced Neuronal Apoptosis via Increased Mitochondrial Fragmentation.

Yang S, Gorshkov K, Lee EM, Xu M, Cheng YS, Sun N, Soheilian F, de Val N, Ming G, Song H, Tang H, Zheng W. Yang S, et al. Front Microbiol. 2020 Dec 23;11:598203. doi: 10.3389/fmicb.2020.598203. eCollection 2020. Front Microbiol. 2020. PMID: 33424801 Free PMC article.

5

Growth hormone rescue cerebellar degeneration in SCA3 transgenic mice.

Wu S, Liu K, Cheng W, Su S, Lin Y, Lin T, Cheng Y, Chang J, Wu Y, Liu C. Wu S, et al. Among authors: cheng y. Biochem Biophys Res Commun. 2020 Aug 20;529(2):467-473. doi: 10.1016/j.bbrc.2020.05.116. Epub 2020 Jul 2. Biochem Biophys Res Commun. 2020. PMID: 32703453

6

Impact of Solid-State Properties on the Aerosolization Performance of Spray-Dried Curcumin Powders.

Zhang Q, Li Y, Li L, Cheng Y, Yu F, Li R, Hou S. Zhang Q, et al. Among authors: cheng y. AAPS PharmSciTech. 2023 Mar 14;24(3):78. doi: 10.1208/s12249-023-02536-5. AAPS PharmSciTech. 2023. PMID: 36918500

7

Comparison of hypoxia-induced pulmonary hypertension rat models caused by different hypoxia protocols.

Cai G, Zhang Y, Wang X, Li S, Cheng Y, Huang X. Cai G, et al. Among authors: cheng y. Exp Lung Res. 2023;49(1):1-11. doi: 10.1080/01902148.2022.2148016. Epub 2022 Nov 24. Exp Lung Res. 2023. PMID: 36420840 Free article.

8

iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II.

Hong J, Cheng YS, Yang S, Swaroop M, Xu M, Beers J, Zou J, Huang W, Marugan JJ, Cai X, Zheng W. Hong J, et al. Exp Cell Res. 2022 Mar 1;412(1):113007. doi: 10.1016/j.yexcr.2021.113007. Epub 2022 Jan 4. Exp Cell Res. 2022. PMID: 34990619 Free PMC article.

9

Nose-to-brain delivery of self-assembled curcumin-lactoferrin nanoparticles: Characterization, neuroprotective effect and in vivo pharmacokinetic study.

Li L, Tan L, Zhang Q, Cheng Y, Liu Y, Li R, Hou S. Li L, et al. Among authors: cheng y. Front Bioeng Biotechnol. 2023 Mar 27;11:1168408. doi: 10.3389/fbioe.2023.1168408. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37051277 Free PMC article.

10

Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells.

Huang W, Cheng YS, Yang S, Swaroop M, Xu M, Huang W, Zheng W. Huang W, et al. Exp Cell Res. 2021 Oct 1;407(1):112785. doi: 10.1016/j.yexcr.2021.112785. Epub 2021 Aug 16. Exp Cell Res. 2021. PMID: 34411609 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

52 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year